Immuno-Oncology Expertise Unlocking the power of the immune system through biomarker identification Utilize molecular and cellular biomarker tests for patient selection and response to improve the clinical success of an immuno-oncology candidate drug. MolecularMD has the expertise to successfully set-up, validate, and implement a novel immuno-oncology CDx. Contact us to learn how MolecularMD optimizes and improves assays to identify the relevant biomarkers that help target a specific therapy to a specific patient. MolecularMD ■ Portland, OR ■ Cambridge, MA ■ www.molecularmd.com bd@molecularmd.com ■ 877-459-4979 ■ @molecularmd1http://www.molecularmd.com http://www.molecularmd.com